54 research outputs found
Estimating and exploiting the degree of independent information in distributed data fusion
Double counting is a major problem in distributed data fusion systems. To maintain flexibility and scalability, distributed data fusion algorithms should just use local information. However globally optimal solutions only exist in highly restricted circumstances. Suboptimal algorithms can be applied in a far wider range of cases, but can be very conservative.
In this paper we present preliminary work to develop
distributed data fusion algorithms that can estimate and
exploit the correlations between the estimates stored in
different nodes in a distributed data fusion network.
We show that partial information can be modelled as
kind of “overweighted” Covariance Intersection algorithm. We motivate the need for an adaptive scheme
by analysing the correlation behaviour of a simple distributed data fusion network and show that it is complicated and counterintuitive. Two simple approaches
to estimate the correlation structure are presented and
their results analysed. We show that significant advantages can be obtained
OSGAR: a scene graph with uncertain transformations
An important problem for augmented reality is registration error. No system can be perfectly tracked, calibrated or modeled. As a result, the overlaid graphics are not aligned perfectly with objects in the physical world. This can be distracting, annoying or confusing. In this paper, we propose a method for mitigating the effects of registration errors that enables application developers to build dynamically adaptive AR displays. Our solution is implemented in a programming toolkit called OSGAR. Built upon OpenSceneGraph (OSG), OSGAR statistically characterizes registration errors, monitors those errors and, when a set of criteria are met, dynamically adapts the display to mitigate the effects of the errors. Because the architecture is based on a scene graph, it provides a simple, familiar and intuitive environment for application developers. We describe the components of OSGAR, discuss how several proposed methods for error registration can be implemented, and illustrate its use through a set of examples
A tracker alignment framework for augmented reality
To achieve accurate registration, the transformations which locate the tracking system components with respect to the environment must be known. These transformations relate the base of the tracking system to the virtual world and the tracking system's sensor to the graphics display. In this paper we present a unified, general calibration method for calculating these transformations. A user is asked to align the display with objects in the real world. Using this method, the sensor to display and tracker base to world transformations can be determined with as few as three measurements
Autonomous Flight in Unknown Indoor Environments
http://multi-science.metapress.com/content/80586kml376k2711/This paper presents our solution for enabling a quadrotor helicopter, equipped with a laser rangefinder sensor, to autonomously explore and map unstructured and unknown indoor environments. While these capabilities are already commodities on ground vehicles, air vehicles seeking the same performance face unique challenges. In this paper, we describe the difficulties in achieving fully autonomous helicopter flight, highlighting the differences between ground and helicopter robots that make it difficult to use algorithms that have been developed for ground robots. We then provide an overview of our solution to the key problems, including a multilevel sensing and control hierarchy, a high-speed laser scan-matching algorithm, an EKF for data fusion, a high-level SLAM implementation, and an exploration planner. Finally, we show experimental results demonstrating the helicopter's ability to navigate accurately and autonomously in unknown environments.National Science Foundation (U.S.) (NSF Division of Information and Intelligent Systems under grant # 0546467)United States. Army Research Office (ARO MAST CTA)Singapore. Armed Force
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer
Background
Selective cyclooxygenase inhibitors may retard the progression of cancer, but they
have enhanced thrombotic potential. We report on cardiovascular adverse events in
patients receiving rofecoxib to reduce rates of recurrence of colorectal cancer.
Methods
All serious adverse events that were cardiovascular thrombotic events were reviewed
in 2434 patients with stage II or III colorectal cancer participating in a randomized,
placebo-controlled trial of rofecoxib, 25 mg daily, started after potentially curative
tumor resection and chemotherapy or radiotherapy as indicated. The trial was terminated
prematurely owing to worldwide withdrawal of rofecoxib. To examine possible
persistent risks, we examined cardiovascular thrombotic events reported up to 24
months after the trial was closed.
Results
The median duration of active treatment was 7.4 months. The 1167 patients receiving
rofecoxib and the 1160 patients receiving placebo were well matched, with a median
follow-up period of 33.0 months (interquartile range, 27.6 to 40.1) and 33.4 months
(27.7 to 40.4), respectively. Of the 23 confirmed cardiovascular thrombotic events,
16 occurred in the rofecoxib group during or within 14 days after the treatment
period, with an estimated relative risk of 2.66 (from the Cox proportional-hazards
model; 95% confidence interval [CI], 1.03 to 6.86; P = 0.04). Analysis of the Antiplatelet
Trialists’ Collaboration end point (the combined incidence of death from
cardiovascular, hemorrhagic, and unknown causes; of nonfatal myocardial infarction;
and of nonfatal ischemic and hemorrhagic stroke) gave an unadjusted relative
risk of 1.60 (95% CI, 0.57 to 4.51; P = 0.37). Fourteen more cardiovascular thrombotic
events, six in the rofecoxib group, were reported within the 2 years after trial
closure, with an overall unadjusted relative risk of 1.50 (95% CI, 0.76 to 2.94;
P = 0.24). Four patients in the rofecoxib group and two in the placebo group died
from thrombotic causes during or within 14 days after the treatment period, and
during the follow-up period, one patient in the rofecoxib group and five patients in
the placebo group died from cardiovascular causes.
Conclusions
Rofecoxib therapy was associated with an increased frequency of adverse cardiovascular
events among patients with a median study treatment of 7.4 months’ duration.
(Current Controlled Trials number, ISRCTN98278138.
Fast Relative Pose Calibration for Visual and Inertial Sensors
Accurate vision-aided inertial navigation depends on proper calibration of the relative pose of the camera and the inertial measurement unit (IMU). Calibration errors introduce bias in the overall motion estimate, degrading navigation performance- sometimes dramatically. However, existing camera-IMU calibration techniques are difficult, time-consuming and often require additional complex apparatus. In this paper, we formulate the camera-IMU relative pose calibration problem in a filtering framework, and propose a calibration algorithm which requires only a planar camera calibration target. The algorithm uses an unscented Kalman filter to estimate the pose of the IMU in a global reference frame and the 6-DoF transform between the camera and the IMU. Results from simulations and experiments with a low-cost solid-state IMU demonstrate the accuracy of the approach.
- …